Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
21,650
+200 (0.93%)
Jan 29, 2026, 3:30 PM KST
37.72%
Market Cap149.48B
Revenue (ttm)66.51B -10.3%
Net Income2.32B
EPS340.76
Shares Out6.97M
PE Ratio62.95
Forward PEn/a
Dividend1,000.00 (4.64%)
Ex-Dividend DateDec 29, 2025
Volume3,624
Average Volume7,454
Open21,350
Previous Close21,450
Day's Range21,100 - 21,700
52-Week Range14,500 - 31,450
Beta-0.37
RSI49.71
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements